Doctolib just bought Medicus Health to enter the UK. £100m+ committed, 150 hires planned, a dedicated R&D centre on primary care. The British GP market has been a duopoly between Optum and TPP for two decades. It's about to be disrupted — from Paris.

A year ago, that headline would have read like an exception. In 2026 it reads like the rule.

The pattern

Pull a few weeks of European tech news and the shape of the move is unmistakable.

Five companies. Different verticals, different stages. Same playbook: buy the beachhead, don't build it.

Why now

Three things changed in the past eighteen months, and they reinforce each other.

Capital cycle.

Late-stage European fundraising windows are tight. Growth equity is selective. The companies sitting on €100–500m of dry powder from rounds raised in 2021–2023 face a clear calculation: spend that capital on slow organic geographic expansion, or compress two years into two months by acquiring an existing operator. The math has shifted decisively toward acquisition.

The scale gap.

Salesforce is a $300bn company. Workday, ServiceNow, Datadog — each well past $50bn. The European challengers that emerged in the last decade are now at the awkward stage where they have product depth, brand, and cash, but lack the geographic and category breadth to compete head-to-head. M&A closes that gap fastest. Brevo's eleven acquisitions are a textbook case: each one filled a hole in the platform that organic build would have taken three years to plug.

Regulatory tailwind.

The EU's posture toward homegrown tech consolidation has softened. The DMA reshuffled which players regulators are watching, and intra-European deals between mid-cap challengers face less scrutiny than they did pre-2023. That matters at the margin — a few percent of deals that used to die in legal review now go through.

Why France over-indexes

Of the names above, four have a French centre of gravity. That's not a coincidence — and reads against the structural cracks the French ecosystem is showing on capital and corporates. That's not a coincidence.

The French ecosystem produced an unusual concentration of founders who learned to operate cross-border the hard way — through fund-raising in London, hiring in Berlin, selling into the UK while working from Paris. By the time their companies hit €100m ARR, they had already absorbed the operational reality of running a multi-country business. That muscle is what M&A integration actually requires.

Add to that a public-private machinery — Bpi, La French Tech, the French Tech 2030 framework — that has trained the ecosystem to think in continental rather than national terms. And the cultural anchor of EU integration: French founders have grown up with the assumption that Europe is one market, even when the legal reality says otherwise.

The result is a generation of CEOs who treat acquisition not as a bolt-on but as the default growth lever past Series C.

What this means, depending on where you sit

If you're a founder.

Three implications, in order of immediacy.

One — being acquired is a real outcome again. The European exit market has been narrow for two years. It's widening, but the buyers are now European mid-caps rather than US strategics. Build relationships with the acquirers in your category early. The Doctolib of your space already has a corporate development team. Most founders don't realise this until twelve months too late.

Two — geographic distance is back as a moat. Until 2023, "local champion" sounded defensive. In 2026 it sounds acquirable. If you're the clear leader in a country a Brevo or a Qonto wants to enter, your enterprise value is being repriced upward — sometimes without you noticing. Run the comp analysis.

Three — the operational bar has moved. Acquirers are now buying at €15–30m ARR, not €50–100m. That means your data infrastructure, your reporting hygiene, your cap table cleanliness all matter at smaller scale than they used to. The companies that get bought are the ones a corporate development team can underwrite in three weeks.

If you're an LP or a co-investor.

The DPI math is starting to look different. European mid-caps have re-emerged as a real exit channel, alongside US strategics and IPO. That changes which funds you back, which positions you size up, and which secondary opportunities you ignore.

It also changes what "category leader" means at the seed and Series A stage. The companies worth backing now are not the ones that look most likely to IPO in seven years. They're the ones that look most likely to be on the shortlist of a Brevo or a Doctolib in three.

If you're a corporate.

Two of the largest threats to your innovation roadmap are no longer US tech giants. They're French and German mid-caps you weren't tracking. They move faster, integrate harder, and price more aggressively than the strategics you've benchmarked against for a decade. The mental model needs updating.

The bigger picture

For two decades, European tech was about defending. The next decade is about acquiring.

None of this is a guarantee. M&A waves end. Capital cycles reverse. The integration of the next ten Penta-style deals will determine whether 2026 looks, in retrospect, like the start of a structural shift or a brief window before the next contraction.

But the direction is clear, and it's unusual. For most of the last twenty years, European tech narrative was either "we're behind the US" or "we're being bought by the US". A third option is now visibly on the table — European companies acquiring across Europe, into the UK, and increasingly into the US. France, for once, is leading rather than following.

Worth watching. Worth playing.